Paula M. Loria
Pfizer (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, RNA Research and Splicing, RNA and protein synthesis mechanisms, Estrogen and related hormone effects, Computational Drug Discovery Methods
Most-Cited Works
- → The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen(1998)2,696 cited
- → Developing predictive assays: The phenotypic screening “rule of 3”(2015)199 cited
- → Myostatin Inhibition Enhances the Effects of Exercise on Performance and Metabolic Outcomes in Aged Mice(2009)173 cited
- → Hepatitis C and steatosis: a reappraisal(2005)160 cited
- → A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor(2022)146 cited
- → A Conserved Postsynaptic Transmembrane Protein Affecting Neuromuscular Signaling in Caenorhabditis elegans(2004)135 cited
- → Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain(2017)125 cited
- → Two Neuronal, Nuclear-Localized RNA Binding Proteins Involved in Synaptic Transmission(2003)107 cited
- → A Small-Molecule Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein Translation(2016)95 cited
- → Review article: diabetes, genetics and ethnicity(2005)86 cited